.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Express Scripts
Fuji
Novartis
Moodys
Farmers Insurance
McKinsey
Merck
Argus Health
Cantor Fitzgerald

Generated: December 16, 2017

DrugPatentWatch Database Preview

Drug Master Files for: dextromethorphan

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
823III7/2/1964NYSCO LABS INCDEXTROMETHORPHAN HYDROBROMIDE (IN BULK TIME RELEASE PELLETIZED FORM)
824I7/21/1964NYSCO LABS INCMETH & FACIL-T.R. CAP W/DEXTROMETHORPHAN,CHLORPHENIRAMINE&PHENYLEPHRIN
6561III8/7/1986TSUJIMOTO KAGAKU KOGYO CO LTDDEXTROMETHORPHAN PHENOLPHTHALINATE
7526III6/13/1988SIGMA F AND D DIV LTDDEXTROMETHORPHAN HYDROBROMIDE
8535III4/12/1990BILCHEM LTDDEXTROMETHORPHAN HYDROBROMIDE USP
10264III5/24/1993LONZA INCDEXTROMETHORPHAN BASE
11935AII4/18/1996WOCKHARDT LTDDEXTROMETHORPHAN HYDROBROMIDE USP
12356AII2/4/1997DIVIS LABORATORIES LTDDEXTROMETHORPHAN HYDROBROMIDE USP
12467III4/15/1997DR REDDYS LABORATORIES LTDDEXTROMETHORPHAN HYDROBROMIDE
13854AII10/16/1998STANDARD CHEM AND PHARM CO LTDDEXTROMETHORPHAN HYDROBROMIDE USP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
McKinsey
Deloitte
Merck
Baxter
Covington
Mallinckrodt
UBS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot